Abbott Laboratories
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Regulation FD disclosureAug 20 →Insiders4 insiders bought $4.4M in 6 open-market buys. 6 insiders sold $688,360, 0 of 7 sales on a 10b5-1 plan.→HoldersBlackRock 7.6%Vanguard 5.7%State Street 4.0%→PeersClosest companies: JNJ, BDX, IART→
From the filings
Figures
- Revenue
- $46.59Blast 12 months
- Net income
- $5.42Blast 12 months
- Operating cash flow
- $9.46Blast 12 months
- Cash and equivalents
- $5.10Bat the last balance sheet
- Total debt
- $32.61Bat the last balance sheet
- Shares outstanding
- 2.00B shareson issue